These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 36177518)

  • 1. Delta variant effect on the clinical course of adolescent COVID-19 patients.
    Çağlar HT; Pekcan S; Yılmaz Aİ; Ünal G; Metin Akcan Ö; Ünsaçar MZ; Özdemir M; Akın F
    Pediatr Pulmonol; 2023 Jan; 58(1):115-121. PubMed ID: 36177518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar.
    Butt AA; Dargham SR; Chemaitelly H; Al Khal A; Tang P; Hasan MR; Coyle PV; Thomas AG; Borham AM; Concepcion EG; Kaleeckal AH; Latif AN; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    JAMA Intern Med; 2022 Feb; 182(2):197-205. PubMed ID: 34935861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of Disease Among Adults Hospitalized with Laboratory-Confirmed COVID-19 Before and During the Period of SARS-CoV-2 B.1.617.2 (Delta) Predominance - COVID-NET, 14 States, January-August 2021.
    Taylor CA; Patel K; Pham H; Whitaker M; Anglin O; Kambhampati AK; Milucky J; Chai SJ; Kirley PD; Alden NB; Armistead I; Meek J; Yousey-Hindes K; Anderson EJ; Openo KP; Teno K; Weigel A; Monroe ML; Ryan PA; Henderson J; Nunez VT; Bye E; Lynfield R; Poblete M; Smelser C; Barney GR; Spina NL; Bennett NM; Popham K; Billing LM; Shiltz E; Abdullah N; Sutton M; Schaffner W; Talbot HK; Ortega J; Price A; Garg S; Havers FP;
    MMWR Morb Mortal Wkly Rep; 2021 Oct; 70(43):1513-1519. PubMed ID: 34710076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-Naïve Korean Children and Adolescents Hospitalized With COVID-19 in 2021.
    Choi YY; Choi SH; Choi JH; Kim DH; Lee JK; Eun BW; Lee H; Kim YK; Ahn B; Song SH; Yun KW
    J Korean Med Sci; 2022 Oct; 37(42):e303. PubMed ID: 36325607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in Disease Severity and Health Care Utilization During the Early Omicron Variant Period Compared with Previous SARS-CoV-2 High Transmission Periods - United States, December 2020-January 2022.
    Iuliano AD; Brunkard JM; Boehmer TK; Peterson E; Adjei S; Binder AM; Cobb S; Graff P; Hidalgo P; Panaggio MJ; Rainey JJ; Rao P; Soetebier K; Wacaster S; Ai C; Gupta V; Molinari NM; Ritchey MD
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):146-152. PubMed ID: 35085225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical study of awake prone positioning treatment in patients with common coronavirus disease 2019 caused by Omicron variant].
    Wang Z; Feng Q; Yu H; Shi L; Xu L
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jun; 34(6):576-580. PubMed ID: 35924510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway.
    Stålcrantz J; Kristoffersen AB; Bøås H; Veneti L; Seppälä E; Aasand N; Hungnes O; Kvåle R; Bragstad K; Buanes EA; Whittaker R
    Scand J Public Health; 2022 Aug; 50(6):676-682. PubMed ID: 35799474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit].
    Markina UA; Fomina DS; Lebedkina MS; Kruglova TS; Chernov AA; Zagrebneva AI; Mutovina ZY; Karaulov AV; Alexeeva EI; Lysenko MA
    Ter Arkh; 2022 Jun; 94(5):675-682. PubMed ID: 36286968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data from the first wave of Covid-19 from the Central Military Hospital, Prague, Czech Republic.
    Bartovská Z; Andrle F; Beran O; Zlámal M; Řezáč D; Murinova I; Holub M
    Epidemiol Mikrobiol Imunol; 2020; 69(4):164-171. PubMed ID: 33445940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant.
    Butt AA; Dargham SR; Loka S; Shaik RM; Chemaitelly H; Tang P; Hasan MR; Coyle PV; Yassine HM; Al-Khatib HA; Smatti MK; Kaleeckal AH; Latif AN; Zaqout A; Almaslamani MA; Al Khal A; Bertollini R; Abou-Samra AB; Abu-Raddad LJ
    Clin Infect Dis; 2022 Aug; 75(1):e361-e367. PubMed ID: 35404391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of COVID-19 Infections in children: A single-center retrospective study.
    Gençeli M; Metin Akcan Ö; Pekcan S; Akin F; Özdemir M; Kiliç AO; Yazar A
    Pediatr Pulmonol; 2022 Oct; 57(10):2533-2539. PubMed ID: 35855567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of COVID-19 in hospitalized children during the Omicron variant predominant period.
    Shoji K; Akiyama T; Tsuzuki S; Matsunaga N; Asai Y; Suzuki S; Iwamoto N; Funaki T; Ohmagari N
    J Infect Chemother; 2022 Nov; 28(11):1531-1535. PubMed ID: 35963599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals.
    Leiner J; Pellissier V; Hohenstein S; König S; Schuler E; Möller R; Nachtigall I; Bonsignore M; Hindricks G; Kuhlen R; Bollmann A
    BMC Infect Dis; 2022 Oct; 22(1):802. PubMed ID: 36303111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hydroxychloroquine on disease progression and ICU admissions in patients with SARS-CoV-2 infection.
    Awad N; Schiller DS; Fulman M; Chak A
    Am J Health Syst Pharm; 2021 Mar; 78(8):689-696. PubMed ID: 33599721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.
    Trobajo-Sanmartín C; Martínez-Baz I; Miqueleiz A; Fernández-Huerta M; Burgui C; Casado I; Baigorría F; Navascués A; Castilla J; Ezpeleta C
    Microbiol Spectr; 2022 Apr; 10(2):e0000822. PubMed ID: 35412379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.